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ABSTRACT
Cancer-associated fibroblasts (CAFs) are the major components of the tumor 
microenvironment. They may drive tumor progression, although the mechanisms 
involved are still poorly understood. Exosomes have emerged as important mediators 
of intercellular communication in cancer. They mediate horizontal transfer of 
microRNAs (miRs), mRNAs and proteins, thus affecting breast cancer progression. 
Differential expression profile analysis identified three miRs (miRs -21, -378e, 
and -143) increased in exosomes from CAFs as compared from normal fibroblasts. 
Immunofluorescence indicated that exosomes may be transferred from CAFs to breast 
cancer cells, releasing their cargo miRs. Breast cancer cells (BT549, MDA-MB-231, 
and T47D lines) exposed to CAF exosomes or transfected with those miRs exhibited 
a significant increased capacity to form mammospheres, increased stem cell and 
epithelial-mesenchymal transition (EMT) markers, and anchorage-independent cell 
growth. These effects were reverted by transfection with anti-miRs. Similarly to CAF 
exosomes, normal fibroblast exosomes transfected with miRs -21, -378e, and -143 
promoted the stemness and EMT phenotype of breast cancer cells. Thus, we provided 
evidence for the first time of the role of CAF exosomes and their miRs in the induction 
of the stemness and EMT phenotype in different breast cancer cell lines. Indeed, CAFs 
strongly promote the development of an aggressive breast cancer cell phenotype.
INTRODUCTION
Breast cancer is the most common cancer in 
women, and is only second to lung cancer for cancer-
related mortality [1]. Tumor epithelial cells coexist in 
carcinomas with different stromal cell types that together 
create the microenvironment of cancer cells. Cancer-
associated fibroblasts (CAFs), the major components 
of tumor stroma, are active fibroblasts that, similarly 
to myofibroblasts, are highly heterogeneous, acquire 
contractile features, and express α-smooth-muscle actin 
(α-SMA) [2]. Active fibroblasts play similar roles in 
wound healing and in cancer, which may be considered 
as a wound that does not heal [3]. CAFs represent 80% 
of the resident fibroblasts in breast tumors. CAFs release 
high levels of growth factors, cytokines, chemokines, and 
metalloproteases that may affect either other stroma cells 
or cancer cells. Accumulated evidence indicates that they 
play an important role in cancer initiation, angiogenesis, 
invasion, and metastasis of breast cancer [4–6]. Thus, 
CAFs represent an attractive target for cancer therapy.
Exosomes are small (40–100 nm) vesicles that 
have emerged as important mediators of intercellular 
communication in cancer. They have been identified 
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in most body fluids, including urine, amniotic fluid, 
serum, saliva, breast milk, cerebrospinal fluid, and nasal 
secretions [7]. Exosomes mediate local and systemic 
cell communication through the horizontal transfer of 
information, such as microRNAs, mRNAs, and proteins. 
Over the last decade, a number of studies has revealed that 
exosomes influence major tumor-related pathways, such as 
invasion, migration, epithelial-to- mesenchymal transition 
(EMT), metastasis, and therapy resistance [8–12].
MicroRNAs (miRs) are a class of non-coding 17–24 
nucleotide-long RNAs that mediate post-transcriptional 
gene silencing. miRs are involved in many biological 
activities such as cell proliferation, cell differentiation, 
cell migration, disease initiation, and progression. Their 
deregulation plays an essential role in the development 
and progression of cancer: miRs are up- or down-regulated 
in malignant tissues compared to the normal counterpart, 
and so can be either oncogenes or tumor suppressors. 
Recently, microRNAs have been identified in exosomes, 
which can be taken up by neighboring or distant cells and 
subsequently promote oncogenic signaling in recipient 
cells upon delivery of the cargo [13–17].
Here, we analyze whether the release of CAF 
exosomes and their specific miR cargo could dictate 
an aggressive phenotype in breast cancer. Our results 
demonstrate that three miRs (miRs -21, -143, and -378e) 
are released from CAF exosomes. When loaded into breast 
cancer cells, they promote important tumorigenic features: 
stemness, EMT, and anchorage-independent cell growth. 
Thus, the release of CAF exosomes may be responsible for 
the delivery of miRs that promote oncogenic signaling in 
breast cancer cells.
RESULTS
Identification of oncogenic miRs in CAF 
exosomes
Breast fibroblasts were isolated from human breast 
biopsies for primary culture. The isolated cultures were 
characterized by immunocytochemistry for CK22 (pan-
keratin) and Western blot analysis for e-cadherin and 
α-SMA (Supplementary Figure 1a, b). Exosomes were 
isolated from breast fibroblast-conditioned media with 
ExoQuick-TC and characterized by Western blot analysis 
for the exosomal markers CD63, CD81, Hsp70, and Alix 
(Supplementary Figure 1c). To identify oncogenic miRs in 
CAF exosomes, we conducted genome-wide expression 
profiling of miRs (nCounter miRNA assay, nanoString 
Technologies, OSU), comparing exosomal miRs derived 
from two breast CAF cultures (patients #3 and #4) and two 
normal fibroblast (NF) cultures (patients #1 and #2). We 
found that three miRs were significantly up-regulated in 
CAF exosomes respect to NF exosomes: miR-21-5p, miR-
378e, and miR-143-3p (Table 1). RT-PCR was conducted 
to confirm the array data. Interestingly, we found that 
miR-143-3p was up-regulated in CAF cells as compared 
to NFs, but we did not observe the same for miR-21-5p or 
miR-378e (Supplementary Figure 2a, b, c). Furthermore, 
we analyzed expression levels of miRs -21, -143 and -378e 
in CAFs from twelve different breast cancer molecular 
subtypes (five luminal A, six luminal B, one HER-2), 
but we did not observe a significant correlation between 
miRs’ levels and molecular subtypes (Supplementary 
Figure 2d).
miRs -21, -143, and -378 expression in breast 
invasive carcinoma patients
We analyzed miRNA expression in a large cohort 
of TCGA database breast cancer patients (744 Breast 
Invasive Carcinoma samples). We found a statistically 
significant positive correlation between miR-143 and 
-378 (p<0.0001) and between miR-143 and -21 (p<0.05) 
expression (Figure 1a). These findings suggest that the co-
expression of these miRs may represent a pro-oncogenic 
signature of Breast Invasive Carcinoma. Furthermore, 
Log-Rank test analysis indicated that patients with lower 
levels of miR-378 had longer overall survival, suggestive 
of a prognostic role of miR-378 (p<0.01) (Figure 1b). In 
addition, miR-143 expression was significantly increased 
in high (III/IV) compared to low (I/II) breast cancer stages 
(p<0.05; Figure 1c).
Breast fibroblast-derived exosomes are 
transferred to T47D cells
To examine whether fibroblast exosomes could 
be transferred to T47D breast cancer cells, we collected 
exosomes from NF- and CAF-conditioned media, and 
fluorescently labeled them with PKH26. T47D cells were 
treated with labeled exosomes for different times, and then 
were stained with DAPI and green ALEXA488-conjugated 
anti-tubulin antibody. Confocal microscopy confirmed the 
ability of T47D cells to take up NF- (patients #2 and #6) 
and CAF- (patient #3) derived exosomes (Supplementary 
Figure 3, Figure 2a). Notably, the uptake was greater 
after 24 hours (Figure 2a). To get further evidence of 
exosome uptake, we collected a z-stack of six images 
(Supplementary Figure 4). NF exosomes (patient #6, 
Supplementary Figure 4a) and CAF exosomes (patient 
#3, Supplementary Figure 4b) were clearly taken up 
by T47D cells after 24 hours, as demonstrated by co-
localization of ALEXA488 and PKH26 signals. These 
results indicate that NF- and CAF-derived exosomes can 
be transferred to T47D cells, and may play a role in breast 
cancer biology.
miRs released by CAFs are shuttled into breast 
cancer cells via exosomes
In order to demonstrate that CAFs vehiculate miRs 
-21, -143, and -378e via exosomes to breast cancer cells, 
we treated T47D cells with isolated CAF- or NF-exosomes 
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(CAF patients #3, #7 and #8, NF patient #6) for 24 hours 
and then assessed miR levels by RT-PCR. T47D cells 
treated with CAF exosomes exhibited increased levels of 
these miRs as compared to either non-treated T47D cells 
or T47D cells treated with NF exosomes (Figure 2b). In 
addition, to visualize the transport of extracellular miRs 
derived from CAFs into T47D cells, we transfected CAFs 
(patient #11) with cy3-labeled miRs (cy3-miRs -21-5p, 
-143-3p, -378e) and then collected exosomes from cell 
media. Then, we cultured T47D cells with these exosomes. 
Confocal microscopy detected the signals of cy3-miRs 
in the cytoplasm of T47D cells (Figure 2c). Notably, as 
shown in z-stack images (Supplementary Figure 5a, b, c), 
cy3-miRs co-localized with the signals of the exosomal 
marker CD63. Taken together, these results suggest that 
CAF-secreted exosomes mediate the shuttling of miRs 
-21, -143, and -378e into T47D cells.
CAF exosomes promote stemness properties, 
EMT phenotype, and anchorage-independent 
cell growth
To investigate the role of CAF exosomes on 
stemness, we studied suspension cultures of T47D cells. 
Briefly, we seeded T47D cells in stem medium in non-
adherent conditions in the absence or presence of NF 
exosomes (patients #5, #6, and #10) or CAF exosomes 
(patients #3, #7 and #9). After four days, we assessed 
the ability of cells to form mammospheres. We observed 
a significant increase in the number (Figure 3a) and 
diameter (Figure 3b) of spheres in T47D cells treated 
with CAF exosomes compared with either non-treated 
or NF exosome-treated T47D cells, indicating that CAF 
exosomes increase the ability to form mammospheres. 
We next investigated whether CAF exosomes had an 
impact on anchorage-independent cell growth with a soft 
agar assay. We found that the treatment of T47D cells 
with CAF exosomes (patients #7, and #12) increased 
the number of colonies as compared to the treatment of 
T47D cells with NF exosomes (#5, #6, and #10) (Figure 
3c, 3d). Furthermore, the treatment of T47D cells with 
CAF exosomes (patients #3, #7, #9, #12 and #13), but 
not NF exosomes (patients #5, #6 and #10), increased 
the expression of stemness markers (oct3/4, nanog, sox2) 
and EMT markers (snail and zeb) at mRNA (Figure 3e) 
and protein levels (Figure 3f). In addition, the treatment 
of T47D cells with CAF exosomes decreased protein 
expression levels of the epithelial marker, e-cadherin 
(Figure 3f). Similar results were obtained in additional 
breast cancer cell lines (BT549 and MDA-MB-231) 
(Figure 3g). Taken together, these results clearly 
demonstrate that CAF exosomes foster cancer progression 
by promoting stemness properties, EMT phenotype, and 
anchorage-independent cell growth in breast cancer cells.
miR-21, miR-143, and miR-378e promote 
stemness, EMT, anchorage-independent cell 
growth, and invasive capacity
To investigate the biological role of the miRs 
included in CAF exosomes, we transfected T47D cells with 
miRs alone or in combination to evaluate synergic effects, 
Table 1: miRNA expression profiles in NF exosomes vs CAF exosomes
Ratio of geom means: NF exosomes vs CAF exosomes Unique id
1 0,537960845 hsa-miR-21-5p
2 0,703937608 hsa-miR-378e
3 0,768350227 hsa-miR-143-3p
4 0,795360008 hsa-miR-1246
5 0,813311489 hsa-miR-1253
6 0,880781514 hsa-miR-155-5p
7 0,938786077 hsa-miR-549
8 1,032793771 hsa-miR-125b-5p
9 1,228928787 hsa-miR-1283
10 1,256584027 hsa-miR-25-3p
11 1,294286206 hsa-miR-302d-3p
Exosomes were isolated from four primary breast fibroblast cultures: two normal and two cancer-associated cultures. 
miRNA screening was performed by microarray, as described in Materials and Methods. Fold-change values were 
generated from the median expression of the miRNAs in the compared groups (NF exosomes vs CAF exosomes). Three 
miRs were found to be up-regulated in CAF exosomes as compared to NF exosomes.
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and then verified whether these miRs affected the stemness 
phenotype of breast cancer cells through a mammosphere 
formation assay. MiR levels upon transfection were 
assessed with Real time PCR (Supplementary Figure 6a). 
There was a significant increase in the number (Figure 
4a) and diameter (Figure 4b) of mammospheres in T47D 
cell cultures transfected with miRs -143, -378e, or -21/-
143/-378e as compared to scrambled controls. On the 
contrary, T47D cells transfected with specific anti-miRs 
displayed a significant decrease in the number (Figure 4c) 
Figure 1: miRs -21, -143, and -378 are co-expressed, miR-378 correlates with prognosis, and miR-143 correlates with 
tumor stages in breast cancer. miR expression was evaluated using 744 Breast Invasive Carcinoma patients from TCGA database. 
Statistically significant co-expression of miRs -143 and -378 levels, and of miRs -143 and -21 levels were identified in the analyzed cohort. 
Statistical significance calculated using Pearson’s correlation analysis. P<0.05 was considered significant a. Kaplan-Meier survival curve: 
correlation between miR-378 and overall survival of 20 highly and 44 poorly miR-378-expressing breast cancer patients in TCGA database. 
Low miR-378 expression predicted a better prognosis in the cohort. The patients were assigned to the high or low miR-378-expressing 
group using the media as a threshold. P-value calculated using Log-Rank test. P<0.05 was considered significant b. A significant increase 
in miR-143 expression was identified in high (III/IV) compared to low (I/II) breast cancer stages. Statistical significance calculated using 
Student’s t-test. P<0.05 was considered significant c.
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Figure 2: Breast fibroblast-derived exosomes are transferred to T47D cells and miRs -21, -143, and -378e are shuttled 
by CAF exosomes into breast cancer cells. T47D cells were cultured in the absence (control) or presence of either NF- (patient #6) 
or CAF- (patient #3) derived PKH26-labeled exosomes for 24 hours. Exosomes were taken up by T47D cells (confocal microscopy, ×60 
original magnification). T47D cells were stained using DAPI (nuclei) and ALEXA488-conjugated anti-tubulin antibody. Scale bar: 10µm 
a. T47D cells were treated 24 hours in the absence (control) or presence of either NF exosomes (patient #6) or CAF exosomes (patients #3, 
#7 and #8). Real Time PCR was performed to evaluate miRs -21, -143, and -378e levels. Data obtained from three independent experiments 
and presented as mean value ± SD. P-value calculated using one-way ANOVA followed by Bonferroni’s post hoc testing. * p<0.05; ** 
p<0.01 (over control). § p<0.05; §§ p<0.01 (over NF ex) b. T47D cells were cultured in the absence (control) or presence of exosomes 
isolated from cy3-miR-CAF#11 (cy3-miRs -21, -143, -378e) for 24 hours. Cy3-labeled miRs were shuttled from CAF#11 exosomes into 
T47D cells (confocal microscopy, ×60 original magnification). T47D cells were stained using DAPI (nuclei) and ALEXA488-conjugated 
anti-CD63 antibody. Scale bar: 10µm c.
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and diameter (Figure 4d) of mammospheres as compared 
to T47D cells transfected with anti-scrambled controls. 
The effects of anti-miR transfection on miR levels were 
verified by Real time PCR (Supplementary Figure 6b). 
Furthermore, we analyzed Aldehyde Dehydrogenase 
(ALDH) activity in T47D cells transfected with miRs 
-21, -143, and -378e for 48h. Interestingly, we observed 
an increased ALDH activity in T47D cells transfected 
with miRs as compared to T47D cells transfected with 
scrambled controls (Figure 4e). Additionally, we assessed 
Figure 3: CAF exosomes promote stemness, epithelial–mesenchymal transition, and anchorage-independent cell 
growth. T47D cells were cultured under non-adherent conditions in stem medium in the absence (control) or presence of either NF 
exosomes (patients #5, #6, and #10) or CAF exosomes (patients #3, #7, and #9). After four days, the capacity of cells to form spheres was 
assessed a. Sphere diameter distribution (control cells and T47D cells treated with either NF#6 ex or CAF#7 ex) for 10 representative fields. 
Scale bar: 100µm b. T47D cells were cultured in the absence (control) or presence of either NF exosomes (patients #5, #6, and #10) or CAF 
exosomes (patients #7, and #12). After 24h, cells were harvested and cultured in soft agar c. Scale bar: 100µm d. T47D cells were cultured 
in the absence (control) or presence of either NF ex (patients #5, #6, and #10) or CAF ex (patients #3, #7, #9, #12 and #13) for 24h e. or 
48h f. Real Time PCR was performed to analyze oct3/4, nanog, sox2, snail and zeb mRNA levels (e). Western blot analysis was performed 
to evaluate nanog, sox2, oct3/4, zeb, e-cadherin and snail protein levels (f). BT549 cells were cultured in the absence (control) or presence 
of either NF exosomes (patient #6) or CAF exosomes (patient #7) for 48h. Western blot analysis was performed to evaluate e-cadherin and 
oct3/4 protein levels. MDA-MB-231 cells were cultured in the absence (control) or presence of either NF exosomes (patient #5) o CAF 
exosomes (patient #12) for 48h. Western blot analysis was performed to evaluate oct3/4 protein level g. Western blot from representative 
experiments is shown. Actin or vinculin were used as loading controls. The experiments were repeated at least three times (f, g). In a, b, c, 
e, data were obtained from three independent experiments and are presented as mean value ± SD. P-value was calculated using one-way 
ANOVA followed by Bonferroni’s post hoc testing. * p<0.05; ** p<0.01; *** p<0,001 (over control); § p<0.05; §§ p<0.01; §§§ p<0,001 
(over NF ex) (a, b, e). P-value was calculated using Student’s t test. * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001 (over control) (c).
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Figure 4: miR-21, miR-143, and miR-378e promote stemness and epithelial–mesenchymal transition.T47D cells were 
transfected with scrambled (scr, control) or miRs -21, -143, and -378e, alone or in combination (final concentration: 100nM). After 48h, 
cells were harvested and cultured under non-adherent conditions in stem medium. After four days, the capacity of cells to form spheres was 
assessed a. Sphere diameter distribution for 10 representative fields. Scale bar: 100µm b. T47D cells were transfected with anti-miRs (alone 
or in combination, final concentration: 200nM) or scrambled anti-miR (anti-miR-scr, control). After 24h, cells were harvested and cultured 
under non-adherent conditions in stem medium. After four days, the capacity of cells to form spheres was assessed c. Sphere diameter 
distribution for 10 representative fields. Scale bar: 50µm d. ALDEFLUOR assays were performed in T47D cells transfected with scrambled 
or miRs -21, -143, and -378e for 48h e. T47D cells were transfected with scrambled, miRs -21, -143, or -378e for 48h f. or 72h g. Real Time 
PCR was performed to analyze oct3/4, nanog, sox2, and snail mRNA levels (f). In addition, T47D cells were transfected with the miRs alone 
or in combination for 72h. Western blot analysis was performed to evaluate nanog, sox2, oct3/4, zeb, and e-cadherin protein levels (g). In 
a, b, c, d, e, f, data were obtained from three independent experiments and are presented as mean value ± SD. P-value was calculated using 
Student’s t test. * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001 (over control). Western blot analysis from representative experiments. 
Actin was used as loading control. The experiments were repeated at least three times (g).
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the impact of the miRs on the expression of stem cell 
and EMT markers by RT-PCR and Western blot analysis. 
T47D cells transfected with the miRs showed increased 
mRNA and protein levels of stemness and EMT markers, 
and decreased levels of e-cadherin protein, as compared 
to scrambled controls (Figure 4f, 4g). Similar results were 
obtained in additional breast cancer cell lines (BT549 
and MDA-MB-231) (Figure 5a, 5b). MiR levels in 
BT549 and MDA-MB-231 cells upon transfection were 
assessed by Real time PCR (Supplementary Figure 6a). 
On the contrary, we found that T47D cells transfected 
with specific anti-miRs exhibited decreased levels of sox2 
mRNA (Figure 5c) and of EMT markers (Figure 5d). 
We then analyzed the effect of the miRs on anchorage-
independent cell growth with a soft agar assay. We 
observed an increased number of colonies in T47D cells 
transfected with miRs as compared to scrambled controls 
(Figure 6a, 6b). Finally, we performed invasion assay in 
BT549 and MDA-MB-231 cells transfected with miR-21, 
miR-143 and miR-378e. Breast cancer cells transfected 
with miRs exhibited higher invasive capacity than cells 
transfected with scrambled controls (Figure 6c, 6d, 6e, 6f). 
Taken together, these results clearly support the idea that 
miRs -21, -143, and -378e, similarly to CAF exosomes, 
promote anchorage-independent cell growth, stemness, 
and EMT phenotype in breast cancer cells.
Over-expression of CAF exosomal miRs in 
NF exosomes promotes stemness and EMT 
phenotype
To demonstrate that CAF exosomes promote 
stemness through the identified miRs, we transfected 
NF exosomes with miR-21, -143, -378e, or a miR-21/-
143/-378e combination with Exo-Fect. miR content in 
transfected exosomes was assessed by Real time PCR 
(Supplementary Figure 6c). When we performed a 
mammosphere formation assay, we observed a significant 
increase in the number (Figure 7a) and diameter (Figure 
7b, c) of T47D spheres in cells treated with NF exosomes 
transfected with miRs compared to cells treated with NF 
exosomes containing scrambled controls. Furthermore, 
treated T47D cells had increased levels of stemness 
(oct3/4, nanog, and sox2) and EMT (snail and zeb) 
markers as compared to control cells (Figure 7d, e). These 
data clearly show that NF exosomes enriched in miRs -21, 
-143, and -378e acquire the ability to promote stemness 
properties and EMT phenotype in breast cancer cells.
DISCUSSION
The crosstalk between cancer cells and their 
surrounding microenvironment is essential for tumor 
progression and the metastatic process. Accumulated 
evidence indicates that CAFs, the major components 
of tumor stroma, promote tumor processes such as 
angiogenesis, motility, metastasis, and therapy resistance 
in several solid tumors [4, 6, 18–21]. Tumor stroma and 
tumor cells communicate not only through classical 
paracrine signaling mechanisms (cytokines, chemokines, 
growth factors), but also through exosomes. Exosomes are 
nano-vesicles that vehiculate lipids, proteins, mRNAs, and 
microRNAs among cells, thereby modulating cell biology 
[22]. It has been recently shown that they play an essential 
role in cancer development, prognosis, progression, and 
therapy resistance [23–25]. In the context of cancer, this 
process entails the transfer of cancer-promoting cellular 
contents between cancer cells and stromal cells within the 
tumor microenvironment or into the circulation to act at 
distant sites, thereby enabling cancer progression [26]. It 
has been shown that melanoma-derived exosomes from 
the primary tumor “educated” their environment to form 
a pro-tumorigenic niche and programmed bone marrow-
derived progenitors at the pre-metastatic site to assume 
a proangiogenic phenotype, thereby enhancing metastatic 
dissemination [11]. Furthermore, fibroblast-secreted 
exosomes promoted breast cancer cell migration through 
WNT-PCP signaling [10]. More recently, it has been 
demonstrated that human CAFs secreted ADAM10-rich 
exosomes that promoted cell motility and activated RhoA 
and Notch signaling in several cancer cells [27].
In order to develop therapeutic approaches, we 
analyzed the miR content of exosomes from breast 
CAFs. We describe here for the first time that CAFs 
promote breast cancer progression through exosome-
mediated delivery of oncogenic miRs to breast cancer 
cells. microRNA sequencing identified increased 
miRs -21, -378e, and -143 levels in CAF exosomes. 
Immunofluorescence revealed transfer of PKH26-labeled 
exosomes and their miR content from fibroblasts to breast 
cancer cells.
miR-21 is a well-characterized oncogenic miR. In 
particular, its presence in breast cancer correlates with 
poor prognosis, regulates EMT phenotype, and promotes 
cancer cell proliferation and invasion [28–30]. Recently, 
exosomal miR-21 has been reported as an EMT promoter 
in oral carcinoma [25]. The tumorigenic role of miR-
143 depends on the cancer type [31, 32], and recent 
findings suggest that it has a critical role in the tumor 
microenvironment of lung cancer, promoting tumor 
growth and neoangiogenesis [33]. MiR-378e has not been 
studied for an oncogenic/oncosuppressive role.
We analyzed miRNA expression in a large cohort 
of breast cancer patients present in the TCGA database. 
We found a statistically significant positive correlation 
between miRs-143 and -378 and between miRs-143 and 
-21 (p<0.05), strongly suggesting that co-expression of 
these miRs may represent a pro-oncogenic signature. 
Furthermore, Log-Rank test analysis indicated that 
patients with lower levels of miR-378 had longer overall 
survival, suggestive of a prognostic role of miR-378 
(p<0.01). Finally, we found that miR-143 expression was 
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Figure 5: Effects of miRs-21, -143, and -378e on stemness and EMT markers in triple-negative breast cancer cells. 
BT549 cells were transfected with miRs: scr, -21, -143, and -378e, for 24h. Real Time PCR was performed to analyze oct3/4, sox2, and 
snail mRNA levels a. In addition, BT549 cells were transfected with these miRs alone or in combination for 48h. Western blot analysis was 
performed to evaluate nanog, oct3/4, sox2, and zeb protein levels b. MDA-MB-231 cells were transfected with miRs: scr, -21, -143, and 
-378e, for 24h. Real Time PCR was performed to analyze oct3/4, nanog, sox2, and snail mRNA levels (a). In addition, MDA-MB-231 cells 
were transfected with these miRs alone or in combination for 48h. Western blot analysis was performed to evaluate zeb, nanog, and oct3/4 
protein levels (b). T47D cells were transfected with anti-miRs: -scr (control), -21, -143, and -378e, for 48h. Real Time PCR was performed 
to analyze sox2 mRNA levels c. In addition, T47D cells were transfected with anti-miRs (alone or in combination; final concentration: 
200nM) for 72h. Western blot analysis was performed to evaluate e-cadherin, zeb, and slug protein levels d. Western blot analysis from 
representative experiments. Actin or α-tubulin were used as loading controls. The experiments were repeated at least three times (b, d). In 
a and c, data were obtained from three independent experiments and are presented as mean value ± SD. P-value calculated using Student’s 
t test. * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001 (over control).
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Figure 6: miRs -21, -143, and -378e promote anchorage-independent cell growth and invasive capacity. T47D cells were 
transfected with scrambled miRs (scr, control), or miRs -21, -143, and -378e, alone or in combination (final concentration: 100nM). After 
24h, cells were harvested and cultured in soft agar. After 3 weeks, the colonies were counted a. Scale bar: 100µm b. Invasion assays were 
performed in BT549 c, d. and MDA-MB-231 e, f. cells transfected with scrambled or miRs -21, -143, and -378e, alone or in combination 
(final concentration: 100nM). After 48h, cells were harvested and cultured in transwell plates coated with matrigel. Invasive cells were fixed 
with Crystal Violet solution. Percentage of invasive cells was evaluated by eluting fixed cells with 1% SDS and reading the absorbance at 
λ570nm. Data were obtained from three independent experiments and presented as mean value ± SD. P-value calculated using Student’s t 
test. * p<0.05; ** p<0.01; *** p<0.001 (over control).
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Figure 7: NF exosomes transfected with miRs -21, -143, -378e, similarly to CAF exosomes, promote stemness and 
epithelial-mesenchymal transition phenotype. NF (patients #5, and #6) were cultured for 48h. Then, exosomes were isolated from 
NF-conditioned media with ExoQuick-TC™ solution, and transfected using Exo-Fect™ solution with scrambled miRs (scr, control), or 
miRs -21, -143, -378e, alone or in combination (final concentration: 130nM). T47D cells were cultured in the presence of NF exosomes 
(patient #5) transfected with either scrambled miRs (control) or miRs for 48h. Cells were harvested and grown under non-adherent 
conditions in stem medium. After four days, the capacity of cells to form spheres was assessed a. Sphere diameter distribution for 10 
representative fields b. Scale bar: 100µm c. In addition, T47D cells were cultured in the presence of NF exosomes (patients #5, and #6) 
transfected with either scrambled miRs (control) or miRs for 24h d or 48h e. Real Time PCR was performed to analyze nanog, sox2, 
and snail mRNA (d). Western blot analysis was performed to evaluate zeb, nanog, and oct3/4 protein levels. Western blot analysis from 
representative experiments. Actin was used as loading control. The experiments were repeated at least three times (e). In a, b, d, data were 
obtained from three independent experiments and are presented as mean value ± SD. P-value calculated using Student’s t test. * p<0.05; ** 
p<0.01; *** p<0.001; **** p<0.0001 (over control).
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significantly increased in high (III/IV) compared to low (I/
II) breast cancer stages (p<0.05).
Many tumors, including breast cancer, are 
maintained by a subpopulation of cells that display stem 
cell properties, known as cancer stem cells (CSCs) [34, 
35]. Analogous to the regulation of normal stem cells by 
their “niche”, CSCs are regulated by, and in turn regulate, 
cells within the tumor microenvironment. Several studies 
have provided evidence that these CSCs mediate tumor 
metastasis and contribute to treatment resistance and 
relapse [36, 37]. Recent findings have shown that the 
hierarchically organized cell populations are more plastic 
than previously imagined [38–40]. Thus, epithelial cells 
may dedifferentiate and thereby enter back into the stem 
cell pool. Thus, therapies aimed at targeting the CSCs 
within a tumor will not be curative if the pool of CSCs can 
be continuously regenerated from plastic, non-cancer stem 
cells capable of dedifferentiating and reentering the CSC 
state. Notably, accumulating evidence indicates that the 
expression of oct3/4, nanog, and sox2 transcription factors 
is strongly correlated with CSCs: knockdown of these 
genes decreased sphere formation and inhibited tumor 
development in xenograft tumor models [41, 42]. The 
transdifferentiation of epithelial cells into mesenchymal 
cells, a process known as epithelial-mesenchymal 
transition (EMT), is integral in development, wound 
healing, and stem cell behavior, and contributes 
pathologically to fibrosis and cancer progression. This 
switch is mediated by key transcription factors, including 
snail and zeb, and is characterized by the loss of epithelial 
marker expressions, such as e-cadherin. In breast 
carcinomas, induction of EMT promotes the generation of 
CSCs that are able to form mammospheres, and, similarly, 
CSCs isolated from tumors express EMT markers [43, 44]. 
In this scenario, discovering the underlying mechanisms 
that promote dedifferentiation processes could provide 
new targets for therapeutic strategies.
In the present study, we demonstrate that CAF 
exosomes and their miRs promote dedifferentiation 
of breast cancer cells. For the first time, we provide 
evidence that CAF exosomal miRs induce stemness 
and EMT phenotype in breast cancer cells. Moreover, 
normal fibroblast exosomes transfected with these miRs 
promoted stemness and EMT, similarly to CAF exosomes. 
Interestingly, we found that breast cancer cells treated with 
CAF exosomes or transfected with miR-143 and miR-
378e showed increased capacity to form mammospheres. 
Importantly, normal fibroblast exosomes, once transfected 
with miRs -378e, and -143, similarly to CAF exosomes, 
promoted the mammosphere formation. On the contrary, 
breast cancer cells co-transfected with combinations of 
specific anti-miRs displayed a strong reduction of these 
effects, thereby underlying a good strategy to prevent 
dedifferentiation of breast cancer cells. Finally, we found 
that CAF exosomes and their miRs increased anchorage-
independent cell growth in breast cancer cells. Our data 
show that the identified miRs does not act in a synergic 
way, but together they may favor an aggressive phenotype: 
miR-21 seems to be the best inducer of anchorage-
independent cell growth and increases stemness and EMT 
markers, while miR-143 and miR-378e are the strongest 
promoters of stemness. In summary, we conclude 
that CAFs regulate the development of an aggressive 
phenotype in breast cancer cells through exosome-
mediated delivery of oncogenic miRs.
MATERIALS AND METHODS
Primary and continuous cells and mammosphere 
cultures
Breast cancer cell lines, T47D, BT549, MDA-
MB-231 from ATCC, were grown in RPMI-1640 medium. 
Primary cultures of fibroblasts, deriving from patients 
treated at the Clinica Mediterranea (Naples, Italy), were 
grown in Dulbecco’s Modified Eagle’s Medium/Nutrient 
F12-Ham (DMEM-F12). Media were supplemented with 
10% heat-inactivated fetal bovine serum (FBS) and 100 
U/ml penicillin/streptomycin. All media and supplements 
were from Sigma-Aldrich (Milan, Italy).
For mammosphere cultures, single-cell suspensions 
were plated at a density of 1,000 cells/ml in Corning ultra-
low attachment multi-well plates. Cells were grown in 
stem medium: serum-free DMEM-F12 (Sigma, Milan, 
Italy) supplemented with B27 (Life technologies, Milan, 
Italy), 20ng/ml EGF (Sigma, Milan, Italy), 10ng/ml 
bFGF (BD Biosciences, Milan, Italy), and 1X antibiotic-
antimycotics (Life technologies, Milan, Italy). After 4-7 
days, mammospheres appeared as spheres of floating 
viable cells.
Isolation of primary cell cultures from human 
breast biopsies
Human breast biopsies (samples from the Clinica 
Mediterranea) were cut by mechanical fragmentation 
with sterile scissors and tongs. Extracellular matrix was 
digested with collagenase (Sigma-Aldrich) overnight 
under continuous agitation at 37°C. The drawn cellular 
suspensions were separated on the basis of their weights 
by two different centrifugations: the first one at 500 rpm 
for 5 minutes to obtain epithelial cell pellets, the second 
one at 1200 rpm 5 minutes to obtain fibroblast pellets.
Immunocytochemistry
The separation between epithelial cells and 
fibroblasts from human breast biopsies was confirmed by 
the cell block technique (Shandon cytoblock kit) followed 
by immunocytochemistry. A primary antibody was used 
for CK22 (pan-keratin), a known epithelial marker, in 
order to discriminate epithelial cells from fibroblasts.
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Exosome isolation
Exosomes were isolated from cell culture media 
of primary fibroblasts that were grown in DMEM-F12 
(Sigma-Aldrich) supplemented with 10% Exo-FBS (FBS 
depleted of exosomes, SBI, System Biosciences) and 
1X antibiotic-antimycotics (Life technologies, Milan, 
Italy). Culture media were centrifuged at 3000 g for 15 
minutes at 4°C or room temperature to remove cellular 
debris. The supernatants were transferred to sterile tubes 
in an appropriate volume of the ExoQuick-TC™ Exosome 
Isolation Reagent (SBI, System Biosciences), considering 
2 ml of ExoQuick-TC™ solution for every 10 ml of cell 
culture medium. Then, the tubes were subjected to mild 
agitation until the separation between the two phases was 
no longer visible. Finally, the tubes were kept at 4°C O/N 
(12 hours at least were necessary). The following day, the 
tubes were centrifuged firstly at 1500 g for 30 minutes, 
and then at 1500 g for 5 minutes (at 4°C or RT). At the 
end of the steps, white/beige exosomal pellets appeared.
RNA extraction and real time PCR
Total RNA (microRNAs and mRNAs) was extracted 
using Trizol (Invitrogen, Milan, Italy) according to the 
manufacturer’s protocol. Reverse transcription of total 
RNA was performed starting from equal amounts of 
total RNA/sample (150/500ng) using miScript reverse 
Transcription Kit (Qiagen, Milan, Italy) for miR analysis, 
and using SuperScript® III Reverse Transcriptase 
(Invitrogen, Milan, Italy) for mRNA analysis. Quantitative 
analysis of miR-21, miR-143, miR-378e and RNU6A 
(as an internal reference) was performed by Real Time 
PCR using specific primers (Qiagen, Milan, Italy) and 
miScript SYBR Green PCR Kit (Qiagen, Milan, Italy). 
Real Time PCR was also used to assess the mRNAs of 
nanog, oct3/4, sox2, snail, zeb, and β-actin (as an internal 
reference), using iQ™ SYBR Green Supermix (Bio-
Rad, Milan, Italy). The primer sequences were: nanog-
fw: 5’-CAAAGGCAAACAACCCACTT-3’, nanog-rv: 
5’-TCTGGAACCAGGTCTTCACC-3’, oct3/4-fw: 
5’-CGAAAGAGAAAGCGAACCAG-3’, oct3/4-
rv: 5’-GCCGGTTACAGAACCACACT-3’, sox2-fw: 
5’-GCACATGAACGGCTGGAGCAACG-3’, sox2-
rv: 5’-TGCTGCGAGTAGGACATGCTGTAGG-3’, 
snail-fw: 5’-AGTGGTTCTTCTGCGCTACT-3’, snail-
rv: 5’-GGGCTGCTGGAAGGTAAACT-3’, zeb-fw: 
5’-CCAGACAGTGTTACCAGGGAGGAG-3’, zeb-rv: 
5’-TGCCCTTCCTTTCCTGTGTCATCC-3’, actin-
fw: 5’-TGCGTGACATTAAGGAGAAG-3’, actin-rv: 
5’-GCTCGTAGCTCTTCTCCA-3’.
The reaction for detection of mRNAs was performed 
in this manner: 95 °C for 5’, 40 cycles of 95 °C for 
30’’, 62 °C for 30’’ and 72 °C for 30’’. The reaction for 
detection of miRs was performed in this manner: 95 °C for 
15’, 40 cycles of 94 °C for 15’’, 55 °C for 30’’ and 70 °C 
for 30’’. All reactions were run in triplicate. The threshold 
cycle (CT) is defined as the fractional cycle number at 
which the fluorescence passes the fixed threshold. For 
relative quantization, the 2(-ΔΔCT) method was used. 
Experiments were carried out in triplicate for each data 
point, and data analysis was performed by using Applied 
Biosystems StepOnePlus™ Real-Time PCR Systems.
NCounter miRNA assay
Exosomes were isolated from four different 
samples of primary fibroblasts: two normal and two 
cancer-associated fibroblasts. Then, exosomal RNA was 
extracted in order to perform an “nCounter miRNA assay” 
(nanoString Technologies, OSU, Columbus, OHIO). 
Eight-hundred human miRs were digitally detected 
and counted in a single reaction without amplification. 
System performance consisted of 6 positive miRNA 
assay controls, 6 negative miRNA assay controls, and 5 
mRNA housekeeping controls. 100ng of purified total 
RNA was used as starting material. miR expression levels 
were measured calculating the ratio of geom. means (NF 
exosomes vs CAF exosomes).
TCGA data analysis
The collection of data from The Cancer Genome 
Atlas (TCGA) platform was compliant with laws and 
regulations for the protection of human subjects, and 
necessary ethical approvals were obtained. Analysis of 
all data was done using GraphPad Prism 6 (San Diego, 
CA, USA). For our analysis, we downloaded BCGSC 
IlluminaHiSeq_miRNASeq (level 3) along with clinical 
information from the TCGA database in July 2015.
Cell and exosome transfection
For transient over-expression/downregulation of 
miRs, cells at 50% confluence were transfected using 
Oligofectamine (Invitrogen, Milan, Italy) and 100nM of 
pre-miR-21, pre-miR-143-3p, pre-miR-378e, or scrambled 
pre-miR; or 200nM of anti-miR-21, anti-miR-143-3p, 
anti-miR-378e, or scrambled anti-miR (Ambion®, Life 
Technologies). For miR over-expression, exosomes 
isolated with ExoQuick-TC™ solution were transfected 
using Exo-Fect™ Exosome Transfection Reagent (SBI, 
System Biosciences) and 130nM of pre-miR-21, pre-miR-
143-3p, pre-miR-378e, or scrambled pre-miR.
Transfection of CAFs with Cy3-labeled-miRs
CAFs were transfected with 10nM of Cy3-labeled 
miRs (miR-21-5p, miR-143-3p, miR-378e, Tebu-bio, 
San Diego, CA, USA) using Oligofectamine (Invitrogen, 
Milan, Italy). Six hours after transfection, cells were 
washed twice with PBS, and the culture media switched 
to fresh DMEM-F12 1% A/A, 10% exo-FBS. After 
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incubation for a day, the culture media were collected and 
used for exosome preparation.
Protein isolation and western blotting
Cells were washed twice in ice-cold PBS, and lysed 
in JS buffer (50mM HEPES ph 7.5 containing 150mM 
NaCl, 1% Glycerol, 1% Triton X100, 1.5mM MgCl
2
, 
5mM EGTA, 1mM Na3VO4, and 1X protease inhibitor 
cocktail). Exosomes were lysed in RIPA lysis buffer 
(Sigma-Aldrich) containing protease and phosphatase 
inhibitors (Roche Diagnostics GmbH, Mannheim, 
Germany). Protein concentration was determined by 
the Bradford assay (Bio-Rad, Milan, Italy) using bovine 
serum albumin (BSA) as the standard, and equal amounts 
of proteins were analyzed by SDS-PAGE (10%, 12% 
or 15% acrylamide). Gels were electroblotted onto 
nitrocellulose membranes (GE Healthcare, Milan, Italy). 
For immunoblot experiments, membranes were blocked 
for 1 hour with 5% non-fat dry milk in Tris Buffered 
Saline (TBS) containing 0,1% Tween-20, and incubated 
at 4°C overnight with primary antibodies. Detection was 
performed by peroxidase-conjugated secondary antibodies 
using the enhanced chemiluminescence system (Thermo, 
Euroclone, Milan, Italy). Primary antibodies used were: 
anti-β-actin and anti-α-tubulin from Sigma-Aldrich 
(Milan, Italy), anti-vinculin, anti-α-SMA, anti-e-cadherin, 
anti-zeb, anti-oct3/4, anti-nanog, anti-sox2, anti-slug, anti-
snail, anti-CD63, anti-hsp70, anti-alix, anti-CD81 from 
Santa Cruz Biotechnology (CA, USA). ImageJ software 
was used to provide WB quantification.
Immunofluorescence analysis
1) Uptake of fibroblast exosomes by T47D cells. 
Once isolated, exosomes were labeled with PKH26, a 
red fluorescent cell membrane linker (Sigma-Aldrich). 
Briefly, exosomes were stained 5 minutes at RT with 
PKH26 (diluted 1:1000 in PBS), then 1ml of BSA 1% 
was added to the tubes and mixed. Finally, the tubes were 
centrifuged at 1500 g for 5 minutes and pellets were put 
in 500µl of PBS. For immunofluorescence, cells grown on 
glass coverslips were treated at different incubation times 
with PKH26-exosomes, washed six times with PBS and 
fixed with 4% paraformaldehyde in PBS for 20 minutes at 
room temperature. The coverslips were washed three times 
in PBS. Then, cells were permeabilized with PBS 0.5% 
Triton X-100 for 15 minutes at room temperature, and 
blocked in PBS 1% bovine serum albumin (BSA) for 15 
minutes. Cells were incubated with anti-tubulin antibody 
(Santa Cruz), diluted in PBS 1% BSA, for 1 hour at 37°C. 
Coverslips were washed 3 times with PBS and treated with 
Alexa Fluor 488 Goat Anti-Mouse IgG (Invitrogen) for 30 
minutes at 37°C. Coverslips were washed and mounted 
with Gold antifade reagent with DAPI (Invitrogen). 
The cells were visualized by confocal microscopy. 
2) Shuttling assays for fluorescently-labeled miRNAs. After 
a day from the transfection of CAFs with Cy3-labeled-
miRs, exosomes were isolated from cell media, and T47D 
cells grown on glass coverslips were treated for 24 hours 
with the isolated exosomes. For immunofluorescence, it was 
used the same protocol as above, but cells were incubated 
with anti-CD63 primary antibody (Santa Cruz), then with 
Alexa Fluor 488 Goat Anti-Rabbit IgG (Invitrogen).
Mammosphere formation assay
T47D cells were suspended 1000 cells/well in 1 
ml of stem medium and plated into ultra-low attachment 
48-well plates in presence of normal fibroblast or CAF 
exosomes. Alternatively, T47D cells were transfected with 
miRs or anti-miRs for 48 hours or 24 hours, respectively. 
Then, 1000 cells/well were suspended in 1 ml of stem 
medium and plated into ultra-low attachment 48-well 
plates. After 4-7 days, the formed mammospheres were 
counted, and the diameters were measured.
ALDEFLUOR assay
The ALDEFLUOR assay was carried out according 
to manufacturer’s (Stemcell Technologies) guidelines. 
Briefly, dissociated single cells were suspended in 
Aldefluor assay buffer containing an ALDH substrate, 
bodipy-aminoacetaldehyde (BAAA) (5µl per milliliter 
of sample), and incubated for 40 min at 37ºC. A fraction 
of cells was incubated under identical conditions in the 
presence of ALDH inhibitor (10µl per milliliter of sample), 
diethylaminobenzaldehyde (DEAB). Cells were analyzed 
using a BD Accuri™ C6 (BD Biosciences) flow cytometer 
and analyzed using the BD Accuri™ C6 software.
Soft-agar assay
104 cells were plated in 60mm dishes in a solution 
containing Dulbecco’s modified Eagle’s medium 2× 
(Sigma, St Louis, MO, USA), TPB Buffer (Difco, BD, 
Franklin Lakes, NJ, USA), and 1.25% of Noble Agar 
(Difco, BD, Franklin Lakes, NJ, USA). Briefly, cells 
were harvested and counted, then a layer of 7ml with the 
solution containing Noble Agar were left to polymerize on 
the bottom of the dishes. Finally, cells were resuspended 
in 2ml of same solution and plated. Cells were left grown 
for 3 weeks in the incubator.
Invasion assay
In vitro invasion assay was performed in 24-well 
Corning Multiwells 6.5mm Transwell® with 8.0µm Pore 
Polycarbonate Membrane Inserts. The lower chamber was 
filled with 600µl of RPMI medium supplemented with 
10%FBS and 1% antibiotic-antimycotics. The top of the 
upper wells was coated with 25µl of Matrigel Basement 
Membrane Matrix (BD) diluted 1:6 in RPMI free medium 
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and allowed to dry out at 37°C at least 4h. Then, 50.000 
cells, previously transfected with miRs for 48h, were 
plated in RPMI free medium in the upper chamber. Cells 
were incubated at 37°C for 20h. Then, cells on the upper 
surface of the membrane were removed mechanically by 
wiping with a cotton swab, and the cells remaining on the 
lower side of the membrane were fixed and stained with 
Crystal Violet solution. Percentage of invasive cells was 
evaluated by eluting Crystal Violet solution with 1% SDS 
and reading the absorbance at λ570nm.
Statistical analysis
All experiments were repeated at least three times. 
Continuous variables are given as mean ± standard 
deviation. For comparisons between two groups, the 
Student’s t test was used to determine differences between 
mean values for normally distributed. Comparisons among 
more than three groups were determined by one-way 
ANOVA followed by Bonferroni’s post hoc testing. All 
data were analyzed for significance using GraphPad Prism 
6 software (San Diego, CA, USA). P values less than 0.05 
were considered significant.
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